Looking for a Paradox alternative?
If you're evaluating moving off Paradox, here's a fair view of what it does well and where NorReach fits differently.
Where Paradox is strong
Excellent conversational, applicant-facing automation (scheduling, screening) at high volume.
Where NorReach is different
Outbound sourcing across email, LinkedIn, WhatsApp, SMS and AI voice — the motion before someone applies.
Inbound/applicant-facing — it engages people in your funnel, not outbound sourcing.
Pricing (sourced, as of 2026 — verify before relying): Not public; enterprise, custom-quoted (as of 2026).
All-in and contacts-based, from €299/mo — not per seat. Every channel and Nora included on every plan. Approved private-beta workspaces get a 14-day trial.
Channels NorReach runs in one platform
- SMS
- AI voice calls
Plus a unified inbox, CRM pipeline and Nora, the built-in AI assistant.
Built-in compliance controls
- EU data residency — your data is hosted in the EU.
- GDPR features: consent tracking, do-not-contact lists and one-click data export. A DPA is available.
- Consent basis is checked before every outbound action; a suppression list blocks opt-outs and bounces.
- EU quiet-hours hold calls, SMS and WhatsApp outside permitted hours.
- AI voice calls disclose they are AI at the start of the call, logged for the EU AI Act (Article 50).
NorReach and Paradox solve overlapping problems. Paradox is a strong choice in conversational recruiting; NorReach is the better fit if you want one platform across email, LinkedIn, WhatsApp, SMS and AI voice, EU data residency, and transparent contacts-based pricing from €299/mo — not per seat.
Get a demoThis comparison reflects sourced public research about Paradox as of 2026 and may be out of date — vendors change features and pricing. It states Paradox's genuine strengths alongside NorReach's. If anything here is inaccurate, tell us and we'll fix it.
See NorReach on your own outreach
Tell us your use case and we'll show you exactly how NorReach would run it — then set you up with a 14-day trial.